HFSA's 20th Annual Scientific Meeting

FDA Special Session – Off-Label Drug Use


  • Scope of the Issue
  • Compelling Cases
  • Risk vs Benefit
  • Who Should Educate?
  • Panel Discussion (30 min)


  • Mona Fiuzat, PharmD, Adjunct Associate Professor, Food and Drug Administration (FDA)
  • Peter Pang, MD, Indiana University School of Medicine


You must be logged in and own this session in order to post comments.